Back to Search
SERGUEI CASTANEDA, M.D.
M.D.
Radiation Oncology Physician
NPI: 1346509460IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
ME154215(FL)MD468296(PA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
OTHER
Class of 2002
Research & Publications (13)
The first homozygous family for prothrombin G20210A polymorphism reported in Latin America.
PMID 18829602·Clin Appl Thromb Hemost·2009
5-case
Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.
PMID 19088027·Clin Cancer Res·2008
7-preclinical
Dasatinib (BMS-354825) pharmacokinetics and pharmacodynamic biomarkers in animal models predict optimal clinical exposure.
PMID 17145844·Clin Cancer Res·2006
7-preclinical
Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex.
PMID 16849648·Blood·2006
8-other
Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels.
PMID 16432168·Mol Cancer Ther·2006
7-preclinical
Self-organized and highly ordered domain structures within swarms of Myxococcus xanthus.
PMID 16421928·Cell Motil Cytoskeleton·2006
8-other
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
PMID 16339673·Ann N Y Acad Sci·2005
3-trial
Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model.
PMID 16061873·Clin Cancer Res·2005
7-preclinical
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
PMID 15947929·Cancer Chemother Pharmacol·2005
7-preclinical
Analysing protein-protein interactions of the Myxococcus xanthus Dif signalling pathway using the yeast two-hybrid system.
PMID 15870463·Microbiology (Reading)·2005
8-other
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.
PMID 15615512·J Med Chem·2004
7-preclinical
Characterization of a Myxococcus xanthus mutant that is defective for adventurous motility and social motility.
PMID 15583161·Microbiology (Reading)·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20405 OLD CUTLER RD
CUTLER BAY, FL 33189 - Phone
- (305) 946-1030
Quick Facts
- NPI
- 1346509460
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 13
Are you this provider?
Claim Your Profile